204 related articles for article (PubMed ID: 8610422)
1. Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model.
Hanaway MJ; Geissler EK; Wang J; Fechner JH; Buelow R; Knechtle SJ
Transplantation; 1996 Apr; 61(8):1222-8. PubMed ID: 8610422
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
[TBL] [Abstract][Full Text] [Related]
3. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells.
Garrovillo M; Ali A; Oluwole SF
Transplantation; 1999 Dec; 68(12):1827-34. PubMed ID: 10628758
[TBL] [Abstract][Full Text] [Related]
4. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720.
Chueh SC; Tian L; Wang M; Wang ME; Stepkowski SM; Kahan BD
Transplantation; 1997 Nov; 64(10):1407-14. PubMed ID: 9392303
[TBL] [Abstract][Full Text] [Related]
5. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
Wasowska B; Baldwin WM; Sanfilippo F
Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
[TBL] [Abstract][Full Text] [Related]
6. Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection.
Murphy B; Kim KS; Buelow R; Sayegh MH; Hancock WW
Transplantation; 1997 Jul; 64(1):14-9. PubMed ID: 9233694
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
[TBL] [Abstract][Full Text] [Related]
8. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
Bishop DK; Shelby J; Eichwald EJ
Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte expression of soluble donor MHC class I antigen via gene transfer inhibits multiple aspects of the antidonor immune response in fully sensitized rat transplant recipients.
Graeb C; Scherer MN; Kroemer A; Jauch KW; Geissler EK
Hum Immunol; 2002 Oct; 63(10):948-54. PubMed ID: 12368047
[TBL] [Abstract][Full Text] [Related]
10. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
Goss JA; Nakafusa Y; Yu S; Flye MW
Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of acquired thymic tolerance induced by a single major histocompatibility complex class I peptide with the dominant epitope: differential analysis of regulatory cytokines in the lymphoid and intragraft compartments.
Oluwole SF; Chowdhury NC; Ingram M; Garrovillo M; Jin MX; Agrawal S
Transplantation; 1999 Aug; 68(3):418-29. PubMed ID: 10459547
[TBL] [Abstract][Full Text] [Related]
12. Use of allochimeric proteins to mitigate graft-versus-host and host-versus-graft immune responses to rat small bowel allografts.
Okamoto M; Stepkowski SM; Wang M; Kahan BD
Transplantation; 2000 Oct; 70(7):1060-7. PubMed ID: 11045643
[TBL] [Abstract][Full Text] [Related]
13. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
Goss JA; Nakafusa Y; Flye MW
Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
[TBL] [Abstract][Full Text] [Related]
14. Direct MHC class I complementary DNA transfer to thymus induces donor-specific unresponsiveness, which involves multiple immunologic mechanisms.
Knechtle SJ; Wang J; Graeb C; Zhai Y; Hong X; Fechner JH; Geissler EK
J Immunol; 1997 Jul; 159(1):152-8. PubMed ID: 9200450
[TBL] [Abstract][Full Text] [Related]
15. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
Gao L; Woo J; Buelow R
J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
[TBL] [Abstract][Full Text] [Related]
16. Prolonged cold ischemic times and less donor-recipient histocompatibility accelerate graft vascular disease.
Czer LS; Wong AV; Soukiasian H; Gallagher S; De Robertis M; Trento A
Transplant Proc; 2011 Dec; 43(10):3863-8. PubMed ID: 22172861
[TBL] [Abstract][Full Text] [Related]
17. Acquired systemic tolerance to rat cardiac allografts induced by intrathymic inoculation of synthetic polymorphic MHC class I allopeptides.
Chowdhury NC; Murphy B; Sayegh MH; Jin MX; Roy DK; Hardy MA; Oluwole SF
Transplantation; 1996 Dec; 62(12):1878-82. PubMed ID: 8990380
[TBL] [Abstract][Full Text] [Related]
18. Use of donor serum to prevent passive transfer of hyperacute rejection.
Wang J; Geissler EK; Fechner JH; Burlingham WJ; Knechtle SJ
J Surg Res; 1994 Jul; 57(1):150-5. PubMed ID: 8041130
[TBL] [Abstract][Full Text] [Related]
19. Treatment with an HLA-peptide and cyclosporine A prolongs rat small bowel allograft survival.
Willetts IE; Tam PK; Morris PJ; Dallman MJ
J Pediatr Surg; 1997 Mar; 32(3):469-72. PubMed ID: 9094020
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of allogeneic heart graft survival in rats by administration of a peptide (a.a. 75-84) from the alpha 1 helix of the first domain of HLA-B7 01.
Cuturi MC; Josien R; Douillard P; Pannetier C; Cantarovich D; Smit H; Ménoret S; Pouletty P; Clayberger C; Soulillou JP
Transplantation; 1995 Mar; 59(5):661-9. PubMed ID: 7886788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
